Vascular News

Vascular News serves as the ultimate hub for the latest updates and insights in the vascular and endovascular fields.

International, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#2135159

United States

#1128408

Health/Medicine

#6203

Traffic sources

Monthly visitors

Articles

Greenberg Lecture encourages ‘move beyond’ binary aortic disease classification

3 days ago | vascularnews.com | Jocelyn Hudson

Sherene Shalhub (Oregon Health and Science University, Portland, USA) set out a new biologically informed framework that “captures the diverse spectrum of arterial fragility and repair outcomes across inherited and acquired aortic disease” during today’s Roy Greenberg Distinguished Lecture on Innovation at the 2025 Vascular Annual Meeting (VAM; 4–7 June, New Orleans, USA).
US FDA grants de novo clearance for Reflow Medical's Spur peripheral retrievable stent system

1 week ago | vascularnews.com | Jocelyn Hudson

Reflow Medical recently announced that the US Food and Drug Administration (FDA) has granted de novo clearance for the company’s Spur peripheral retrievable stent system, which is designed for the treatment of de novo or restenotic lesions following predilatation in patients with infrapopliteal arterial disease.
Vascular News Europe 106 – June 2025 - Vascular News

1 week ago | vascularnews.com | Jocelyn Hudson

Save my name, email, and website in this browser for the next time I comment.
BD to initiate real-world patient registry for Rotarex atherectomy system

1 week ago | vascularnews.com | Eva Malpass

BD has announced plans to initiate a patient data registry for the Rotarex atherectomy system to measure real-world outcomes for patients with peripheral arterial disease (PAD). Known as XTRACT, this prospective, multicentre, single-arm, post-market registry study will assess the clinical performance of the Rotarex atherectomy system in the treatment of US patients with PAD lesions.
Vascular surgery: Palliative surgery?

2 weeks ago | vascularnews.com | Jocelyn Hudson

Vascular News is pleased to announce Adam Talbot (Manchester, UK) as its new Launch Pad columnist, taking over from Sarah Sillito. In his first column, Talbot writes about “reframing success” in vascular surgery and embracing the increasingly palliative aspect of the specialty. Vascular surgery has long been associated with technically complex procedures and life-saving interventions.
“Bringing communities together is what is at the core of CX Aortic Live”

2 weeks ago | vascularnews.com | Jocelyn Hudson

Building on the success of 2024, CX Aortic Live 2025 (11–12 November, Vienna, Austria) will bring together a multidisciplinary global faculty to share the latest techniques and technologies in open, hybrid and endovascular aortic care. CX Aortic Live is the only global meeting dedicated exclusively to the standalone aorta—from the valve to the iliac arteries.
Inaugural Edinburgh Aortic Summit to showcase “the old, the new and the future”

2 weeks ago | vascularnews.com | Jocelyn Hudson

Orwa Falah (Edinburgh Royal Infirmary, Edinburgh, UK), chair of the Edinburgh Aortic Summit (EAS), speaks to Vascular News ahead of this year’s inaugural meeting. Falah explains that EAS 2025, set to be held 12–13 June in Edinburgh, UK, aims to bring together specialists from vascular surgery, cardiac surgery, anaesthesia, and interventional radiology to discuss “the old, the new and the future” in aortic care.
From Brazil to Baylor: Oderich assumes coveted role at cardiovascular “powerhouse”

3 weeks ago | vascularnews.com | Jocelyn Hudson

Following in the footsteps of some of the pioneers of cardiovascular surgery, Gustavo Oderich recently stepped into position as the Michael E DeBakey distinguished chair in surgery, professor of surgery, chief of vascular and endovascular surgery and director for the Center for Aortic Surgery at Baylor College of Medicine and Texas Heart Institute in Houston, USA.
Reality check: Study brings “significant” gap between randomised and real-world vascular patient populations into sharp focus

3 weeks ago | vascularnews.com | Jocelyn Hudson

The randomised data foundation on which clinicians base decision-making for vascular surgery patients is derived from populations that do not represent the patients they see and treat on a day-to-day basis, a new research paper has found. The review, recently published in BJS Open, involved a comparison of 307 randomised clinical trials including 66,449 patients and UK National Vascular Registry (NVR) data for 119,019 patients.
CX 2025: Cost-effectiveness outcomes defy expectations in latest BEST-CLI data drop

3 weeks ago | vascularnews.com | Jocelyn Hudson

A comment from Andrew Holden (Auckland City Hospital, Auckland, New Zealand) conveyed surprise at new cost-effectiveness data from the BEST-CLI trial that were shared at the 2025 Charing Cross (CX) Symposium (23–25 April, London, UK).